We have observed
1 EP application
Franck Claude Edouard Tetaz
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after September 06, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
MODULATION OF GHRELIN LEVELS AND GHRELIN/UNACYLATED GHRELIN RATIO USING UNACYLATED GHRELIN